Literature DB >> 19821053

Role of aldose reductase in the high glucose induced expression of fibronectin in human mesangial cells.

Ping Huang1, Yuejuan Zhang, Tao Jiang, Wenjiao Zeng, Nong Zhang.   

Abstract

Aldose reductase (AR) has emerged as a key contributor to the diabetic nephropathy (DN), however, the mechanisms by which AR increases DN remain poorly understood. Here, we report that exposure to high glucose (HG) stimulates fibronectin (FN) from human mesangial cells in culture. Our results show that exposure to HG and overexpression AR increase the expression of FN. This increase was prevented by the AR inhibitors sorbinil and zopolrestat. Treatment with HG and transfected with plasmid PcDNA3.0-AR, resulted in phosphorylation and activation of ERK, JNK and AKT signaling pathway, and increase the expression of FN. Treatment with inhibitor of JNK and AKT signaling pathway decreased the expression of FN. These results show that inhibition of AR may be useful to prevented extracellular matrix (ECM) deposition in diabetic nephropathy, which is regulated by JNK and AKT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19821053     DOI: 10.1007/s11033-009-9869-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  22 in total

1.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

2.  The pathobiology of diabetic complications: a unifying mechanism.

Authors:  Michael Brownlee
Journal:  Diabetes       Date:  2005-06       Impact factor: 9.461

Review 3.  Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options.

Authors:  Satish K Srivastava; Kota V Ramana; Aruni Bhatnagar
Journal:  Endocr Rev       Date:  2005-04-06       Impact factor: 19.871

Review 4.  Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: possible role in diabetic nephropathy.

Authors:  S V McLennan; E Fisher; S Y Martell; A K Death; P F Williams; J G Lyons; D K Yue
Journal:  Kidney Int Suppl       Date:  2000-09       Impact factor: 10.545

Review 5.  The role of taurine in diabetes and the development of diabetic complications.

Authors:  S H Hansen
Journal:  Diabetes Metab Res Rev       Date:  2001 Sep-Oct       Impact factor: 4.876

6.  Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells.

Authors:  Sanjay Srivastava; Kota V Ramana; Ravinder Tammali; Satish K Srivastava; Aruni Bhatnagar
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

7.  Nitric oxide up-regulates aldose reductase expression in rat vascular smooth muscle cells: a potential role for aldose reductase in vascular remodeling.

Authors:  H G Seo; T Nishinaka; C Yabe-Nishimura
Journal:  Mol Pharmacol       Date:  2000-04       Impact factor: 4.436

8.  Interaction between the polyol pathway and non-enzymatic glycation on mesangial cell gene expression.

Authors:  Qinghong Dan; Rachel L C Wong; Shinan Yin; Sookja K Chung; Stephen S M Chung; Karen S L Lam
Journal:  Nephron Exp Nephrol       Date:  2004

9.  The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus.

Authors:  K Borch-Johnsen; P K Andersen; T Deckert
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

10.  Aldose reductase structures: implications for mechanism and inhibition.

Authors:  O El-Kabbani; F Ruiz; C Darmanin; R P-T Chung
Journal:  Cell Mol Life Sci       Date:  2004-04       Impact factor: 9.261

View more
  1 in total

1.  Renoprotective Effects of Aldose Reductase Inhibitor Epalrestat against High Glucose-Induced Cellular Injury.

Authors:  Heba El Gamal; Ali Hussein Eid; Shankar Munusamy
Journal:  Biomed Res Int       Date:  2017-03-12       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.